✦ LIBER ✦

Subcutaneous factor IX administration to patients with hemophilia B

✍ Scribed by Mauro Berrettini; Paolo Iorio; Giuseppe G. Nenci; Paolo Arcieri; Guglilmo Mariani

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 221 KB
Volume: 47
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830470116

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First factor IX mutations in Albanian he

First factor IX mutations in Albanian hemophilia B patients

✍ Giancarlo Castaman; Sofia H. Giacomelli; Rossella Ghiotto; Keti Pojani; Francesc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

Factor VIIa levels are decreased in pati

Factor VIIa levels are decreased in patients with hemophilia B

✍ Juzo Matsuda; Noriko Saitoh; Kengo Gohchi; Miyo Tsukamoto; Moritaka Gotoh; Hidej 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

A new case of severe hemophilia B leyden

A new case of severe hemophilia B leyden, associated with a G to C mutation at position -6 of the factor IX promoter

✍ P. Nguyen; P. Cornillet; G. Potron 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 1 views

Trilineage response to recombinant human

Trilineage response to recombinant human granulocyte colony-stimulating factor administration in a patient with myelodysplastic syndrome

✍ Caroline Rey; Brigiette Bader-Meunier; Gérard Tertian; Francçise Mielot; Gil Tch 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB 👁 2 views

Appearance of an inhibitor to factor VII

Appearance of an inhibitor to factor VIII in a hemophilia A patient with HIV infection treated with combination anti-retroviral therapy

✍ Bleak, Shirley; Rodgers, George M. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

Prospective randomized comparison of mor

Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage–colony stimulating factor in patients with soft tissue or bone sarcoma

✍ Dilek Dinçol; Mustafa Samur; Ali Pamir; Orhan Şencan; Hakan Akbulut; Bülent Yalç 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

## BACKGROUND. Hematopoietic growth factors (HGFs) have been used to reduce the neutropenic complications of cytotoxic chemotherapy so that higher doses may be given. The authors have previously shown that endogenous serum granulocytecolony stimulating factor (G-CSF) and granulocyte-macrophage-colo